[1]
van Heuvel Y, Schatz S, Rosengarten JF, Stitz J. Infectious RNA: Human Immunodeficiency Virus (HIV) Biology, Therapeutic Intervention, and the Quest for a Vaccine. Toxins. 2022 Feb 14:14(2):. doi: 10.3390/toxins14020138. Epub 2022 Feb 14 [PubMed PMID: 35202165]
[2]
Meissner ME, Talledge N, Mansky LM. Molecular Biology and Diversification of Human Retroviruses. Frontiers in virology (Lausanne, Switzerland). 2022:2():. pii: 872599. doi: 10.3389/fviro.2022.872599. Epub 2022 Jun 2 [PubMed PMID: 35783361]
[3]
Aiken C, Rousso I. The HIV-1 capsid and reverse transcription. Retrovirology. 2021 Sep 25:18(1):29. doi: 10.1186/s12977-021-00566-0. Epub 2021 Sep 25 [PubMed PMID: 34563203]
[4]
Zhang J, Ma B, Han X, Ding S, Li Y. Global, regional, and national burdens of HIV and other sexually transmitted infections in adolescents and young adults aged 10-24 years from 1990 to 2019: a trend analysis based on the Global Burden of Disease Study 2019. The Lancet. Child & adolescent health. 2022 Nov:6(11):763-776. doi: 10.1016/S2352-4642(22)00219-X. Epub 2022 Sep 13 [PubMed PMID: 36108664]
[5]
. Consolidated Guidelines on HIV Prevention, Testing, Treatment, Service Delivery and Monitoring: Recommendations for a Public Health Approach. 2021 Jul:(): [PubMed PMID: 34370423]
[6]
Beyrer C. HIV epidemiology update and transmission factors: risks and risk contexts--16th International AIDS Conference epidemiology plenary. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2007 Apr 1:44(7):981-7 [PubMed PMID: 17342654]
[7]
Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, Wodak A, Panda S, Tyndall M, Toufik A, Mattick RP, 2007 Reference Group to the UN on HIV and Injecting Drug Use. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet (London, England). 2008 Nov 15:372(9651):1733-45. doi: 10.1016/S0140-6736(08)61311-2. Epub 2008 Sep 23 [PubMed PMID: 18817968]
[8]
Fernandes RM, Cary M, Duarte G, Jesus G, Alarcão J, Torre C, Costa S, Costa J, Carneiro AV. Effectiveness of needle and syringe Programmes in people who inject drugs - An overview of systematic reviews. BMC public health. 2017 Apr 11:17(1):309. doi: 10.1186/s12889-017-4210-2. Epub 2017 Apr 11 [PubMed PMID: 28399843]
[9]
Kahn JO, Walker BD. Acute human immunodeficiency virus type 1 infection. The New England journal of medicine. 1998 Jul 2:339(1):33-9 [PubMed PMID: 9647878]
[10]
Xu Y, Ollerton MT, Connick E. Follicular T-cell subsets in HIV infection: recent advances in pathogenesis research. Current opinion in HIV and AIDS. 2019 Mar:14(2):71-76. doi: 10.1097/COH.0000000000000525. Epub [PubMed PMID: 30585797]
[11]
Chadburn A, Abdul-Nabi AM, Teruya BS, Lo AA. Lymphoid proliferations associated with human immunodeficiency virus infection. Archives of pathology & laboratory medicine. 2013 Mar:137(3):360-70. doi: 10.5858/arpa.2012-0095-RA. Epub [PubMed PMID: 23451747]
[12]
Thompson MA, Horberg MA, Agwu AL, Colasanti JA, Jain MK, Short WR, Singh T, Aberg JA. Primary Care Guidance for Persons With Human Immunodeficiency Virus: 2020 Update by the HIV Medicine Association of the Infectious Diseases Society of America. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2021 Dec 6:73(11):e3572-e3605. doi: 10.1093/cid/ciaa1391. Epub [PubMed PMID: 33225349]
[13]
Centers for Disease Control and Prevention (CDC). Revised surveillance case definition for HIV infection--United States, 2014. MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports. 2014 Apr 11:63(RR-03):1-10 [PubMed PMID: 24717910]
[14]
Brew BJ, Garber JY. Neurologic sequelae of primary HIV infection. Handbook of clinical neurology. 2018:152():65-74. doi: 10.1016/B978-0-444-63849-6.00006-2. Epub [PubMed PMID: 29604985]
[15]
Robb ML, Eller LA, Kibuuka H, Rono K, Maganga L, Nitayaphan S, Kroon E, Sawe FK, Sinei S, Sriplienchan S, Jagodzinski LL, Malia J, Manak M, de Souza MS, Tovanabutra S, Sanders-Buell E, Rolland M, Dorsey-Spitz J, Eller MA, Milazzo M, Li Q, Lewandowski A, Wu H, Swann E, O'Connell RJ, Peel S, Dawson P, Kim JH, Michael NL, RV 217 Study Team. Prospective Study of Acute HIV-1 Infection in Adults in East Africa and Thailand. The New England journal of medicine. 2016 Jun 2:374(22):2120-30. doi: 10.1056/NEJMoa1508952. Epub 2016 May 18 [PubMed PMID: 27192360]
[16]
Lavreys L, Baeten JM, Chohan V, McClelland RS, Hassan WM, Richardson BA, Mandaliya K, Ndinya-Achola JO, Overbaugh J. Higher set point plasma viral load and more-severe acute HIV type 1 (HIV-1) illness predict mortality among high-risk HIV-1-infected African women. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2006 May 1:42(9):1333-9 [PubMed PMID: 16586394]
[17]
Lapins J, Gaines H, Lindbäck S, Lidbrink P, Emtestam L. Skin and mucosal characteristics of symptomatic primary HIV-1 infection. AIDS patient care and STDs. 1997 Apr:11(2):67-70 [PubMed PMID: 11361765]
[18]
Osmond D, Chaisson R, Moss A, Bacchetti P, Krampf W. Lymphadenopathy in asymptomatic patients seropositive for HIV. The New England journal of medicine. 1987 Jul 23:317(4):246 [PubMed PMID: 3474522]
[19]
Suryana K, Suharsono H, Antara IGPJ. Factors Associated with Oral Candidiasis in People Living with HIV/AIDS: A Case Control Study. HIV/AIDS (Auckland, N.Z.). 2020:12():33-39. doi: 10.2147/HIV.S236304. Epub 2020 Jan 14 [PubMed PMID: 32021484]
[20]
Apalata T, Longo-Mbenza B, Sturm A, Carr W, Moodley P. Factors Associated with Symptomatic Vulvovaginal Candidiasis: A Study among Women Attending a Primary Healthcare Clinic in Kwazulu-Natal, South Africa. Annals of medical and health sciences research. 2014 May:4(3):410-6. doi: 10.4103/2141-9248.133470. Epub [PubMed PMID: 24971218]
[21]
Ottria L, Lauritano D, Oberti L, Candotto V, Cura F, Tagliabue A, Tettamanti L. Prevalence of HIV-related oral manifestations and their association with HAART and CD4+ T cell count: a review. Journal of biological regulators and homeostatic agents. 2018 Jan-Feb:32(2 Suppl. 1):51-59 [PubMed PMID: 29460518]
[22]
Brown P, Elmasry S, Olagunju A, Garcia S, Sarihan M. A Case of Disseminated Cutaneous Herpes Simplex Virus-1 as the First Manifestation of Human Immunodeficiency Virus Infection. Journal of investigative medicine high impact case reports. 2021 Jan-Dec:9():23247096211045245. doi: 10.1177/23247096211045245. Epub [PubMed PMID: 34521234]
[23]
Timoney MT, Atrio JM, McGowan JP, Fine SM, Vail R, Merrick ST, Radix A, Hoffmann CJ, Gonzalez CJ. Screening for Cervical Dysplasia and Cancer in Adults With HIV. 2022 Mar:(): [PubMed PMID: 35467815]
[24]
Knight CL. Physical Examination in Human Immunodeficiency Virus Disease. The Medical clinics of North America. 2022 May:106(3):527-536. doi: 10.1016/j.mcna.2022.01.001. Epub 2022 Apr 4 [PubMed PMID: 35491072]
[25]
Saag MS. HIV Infection - Screening, Diagnosis, and Treatment. The New England journal of medicine. 2021 Jun 3:384(22):2131-2143. doi: 10.1056/NEJMcp1915826. Epub [PubMed PMID: 34077645]
[26]
Goldschmidt R, Chu C. HIV Infection in Adults: Initial Management. American family physician. 2021 Apr 1:103(7):407-416 [PubMed PMID: 33788514]
[27]
Burudpakdee C, Near AM, Tse J, Faccone J, Rodriguez PL, Karichu JK, Cheng MM. Real-world HIV diagnostic testing patterns in the United States. The American journal of managed care. 2022 Feb 1:28(2):e42-e48. doi: 10.37765/ajmc.2022.88826. Epub 2022 Feb 1 [PubMed PMID: 35139295]
[28]
Gandhi RT, Bedimo R, Hoy JF, Landovitz RJ, Smith DM, Eaton EF, Lehmann C, Springer SA, Sax PE, Thompson MA, Benson CA, Buchbinder SP, Del Rio C, Eron JJ Jr, Günthard HF, Molina JM, Jacobsen DM, Saag MS. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2022 Recommendations of the International Antiviral Society-USA Panel. JAMA. 2023 Jan 3:329(1):63-84. doi: 10.1001/jama.2022.22246. Epub [PubMed PMID: 36454551]
[29]
Lévy Y, Lelièvre JD, Assoumou L, Aznar E, Pulido F, Tambussi G, Crespo M, Meybeck A, Molina JM, Delaugerre C, Izopet J, Peytavin G, Cardon F, Diallo A, Lancar R, Béniguel L, Costagliola D. Addition of Maraviroc Versus Placebo to Standard Antiretroviral Therapy for Initial Treatment of Advanced HIV Infection: A Randomized Trial. Annals of internal medicine. 2020 Mar 3:172(5):297-305. doi: 10.7326/M19-2133. Epub 2020 Feb 11 [PubMed PMID: 32040959]
[30]
Volberding PA. HIV Treatment and Prevention: An Overview of Recommendations From the IAS-USA Antiretroviral Guidelines Panel. Topics in antiviral medicine. 2017 Feb/Mar:25(1):17-24 [PubMed PMID: 28402930]
[31]
Reeves I, Cromarty B, Deayton J, Dhairyawan R, Kidd M, Taylor C, Thornhill J, Tickell-Painter M, van Halsema C. British HIV Association guidelines for the management of HIV-2 2021. HIV medicine. 2021 Dec:22 Suppl 4():1-29. doi: 10.1111/hiv.13204. Epub [PubMed PMID: 34927347]
[32]
Raugi DN, Smith RA, Ba S, Toure M, Traore F, Sall F, Pan C, Blankenship L, Montano A, Olson J, Dia Badiane NM, Mullins JI, Kiviat NB, Hawes SE, Sow PS, Gottlieb GS, University of Washington-Dakar HIV-2 Study Group. Complex patterns of protease inhibitor resistance among antiretroviral treatment-experienced HIV-2 patients from Senegal: implications for second-line therapy. Antimicrobial agents and chemotherapy. 2013 Jun:57(6):2751-60. doi: 10.1128/AAC.00405-13. Epub 2013 Apr 9 [PubMed PMID: 23571535]
[33]
Smith RA, Raugi DN, Pan C, Sow PS, Seydi M, Mullins JI, Gottlieb GS, University of Washington-Dakar HIV-2 Study Group. In vitro activity of dolutegravir against wild-type and integrase inhibitor-resistant HIV-2. Retrovirology. 2015 Feb 5:12():10. doi: 10.1186/s12977-015-0146-8. Epub 2015 Feb 5 [PubMed PMID: 25808007]
[34]
Munthali C, Taegtmeyer M, Garner PG, Lalloo DG, Squire SB, Corbett EL, Ford N, MacPherson P. Diagnostic accuracy of the WHO clinical staging system for defining eligibility for ART in sub-Saharan Africa: a systematic review and meta-analysis. Journal of the International AIDS Society. 2014:17(1):18932. doi: 10.7448/IAS.17.1.18932doi: 18932. Epub 2014 Jun 12 [PubMed PMID: 24929097]
[35]
Baveewo S, Ssali F, Karamagi C, Kalyango JN, Hahn JA, Ekoru K, Mugyenyi P, Katabira E. Validation of World Health Organisation HIV/AIDS clinical staging in predicting initiation of antiretroviral therapy and clinical predictors of low CD4 cell count in Uganda. PloS one. 2011 May 12:6(5):e19089. doi: 10.1371/journal.pone.0019089. Epub 2011 May 12 [PubMed PMID: 21589912]
[36]
Morpeth SC, Crump JA, Shao HJ, Ramadhani HO, Kisenge PR, Moylan CA, Naggie S, Caram LB, Landman KZ, Sam NE, Itemba DK, Shao JF, Bartlett JA, Thielman NM. Predicting CD4 lymphocyte count {200 cells/mm(3) in an HIV type 1-infected African population. AIDS research and human retroviruses. 2007 Oct:23(10):1230-6 [PubMed PMID: 17961109]
[37]
Teeraananchai S, Kerr SJ, Amin J, Ruxrungtham K, Law MG. Life expectancy of HIV-positive people after starting combination antiretroviral therapy: a meta-analysis. HIV medicine. 2017 Apr:18(4):256-266. doi: 10.1111/hiv.12421. Epub 2016 Aug 31 [PubMed PMID: 27578404]
[38]
Engsig FN, Zangerle R, Katsarou O, Dabis F, Reiss P, Gill J, Porter K, Sabin C, Riordan A, Fätkenheuer G, Gutiérrez F, Raffi F, Kirk O, Mary-Krause M, Stephan C, de Olalla PG, Guest J, Samji H, Castagna A, d'Arminio Monforte A, Skaletz-Rorowski A, Ramos J, Lapadula G, Mussini C, Force L, Meyer L, Lampe F, Boufassa F, Bucher HC, De Wit S, Burkholder GA, Teira R, Justice AC, Sterling TR, M Crane H, Gerstoft J, Grarup J, May M, Chêne G, Ingle SM, Sterne J, Obel N, Antiretroviral Therapy Cohort Collaboration (ART-CC) and the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord. Long-term mortality in HIV-positive individuals virally suppressed for }3 years with incomplete CD4 recovery. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2014 May:58(9):1312-21. doi: 10.1093/cid/ciu038. Epub 2014 Jan 22 [PubMed PMID: 24457342]
[39]
Kelley CF, Kitchen CM, Hunt PW, Rodriguez B, Hecht FM, Kitahata M, Crane HM, Willig J, Mugavero M, Saag M, Martin JN, Deeks SG. Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2009 Mar 15:48(6):787-94. doi: 10.1086/597093. Epub [PubMed PMID: 19193107]
[40]
Greub G, Ledergerber B, Battegay M, Grob P, Perrin L, Furrer H, Burgisser P, Erb P, Boggian K, Piffaretti JC, Hirschel B, Janin P, Francioli P, Flepp M, Telenti A. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet (London, England). 2000 Nov 25:356(9244):1800-5 [PubMed PMID: 11117912]
[41]
Sax PE, Erlandson KM, Lake JE, Mccomsey GA, Orkin C, Esser S, Brown TT, Rockstroh JK, Wei X, Carter CC, Zhong L, Brainard DM, Melbourne K, Das M, Stellbrink HJ, Post FA, Waters L, Koethe JR. Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2020 Sep 12:71(6):1379-1389. doi: 10.1093/cid/ciz999. Epub [PubMed PMID: 31606734]
[42]
Samandari T, Wiener J, Huang YA, Hoover KW, Siddiqi AE. Impact of viral suppression among persons with HIV upon estimated HIV incidence between 2010 and 2015 in the United States. PloS one. 2020:15(10):e0240727. doi: 10.1371/journal.pone.0240727. Epub 2020 Oct 16 [PubMed PMID: 33064746]
[43]
Walensky RP, Paltiel AD. New USPSTF Guidelines for HIV Screening and Preexposure Prophylaxis (PrEP): Straight A's. JAMA network open. 2019 Jun 5:2(6):e195042. doi: 10.1001/jamanetworkopen.2019.5042. Epub 2019 Jun 5 [PubMed PMID: 31184696]
[44]
. Screening for HIV Infection: Recommendation Statement. American family physician. 2019 Nov 15:100(10):Online [PubMed PMID: 31730320]
[45]
Eisinger RW, Dieffenbach CW, Fauci AS. HIV Viral Load and Transmissibility of HIV Infection: Undetectable Equals Untransmittable. JAMA. 2019 Feb 5:321(5):451-452. doi: 10.1001/jama.2018.21167. Epub [PubMed PMID: 30629090]
[46]
Rodger AJ, Cambiano V, Bruun T, Vernazza P, Collins S, van Lunzen J, Corbelli GM, Estrada V, Geretti AM, Beloukas A, Asboe D, Viciana P, Gutiérrez F, Clotet B, Pradier C, Gerstoft J, Weber R, Westling K, Wandeler G, Prins JM, Rieger A, Stoeckle M, Kümmerle T, Bini T, Ammassari A, Gilson R, Krznaric I, Ristola M, Zangerle R, Handberg P, Antela A, Allan S, Phillips AN, Lundgren J, PARTNER Study Group. Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy. JAMA. 2016 Jul 12:316(2):171-81. doi: 10.1001/jama.2016.5148. Epub [PubMed PMID: 27404185]
[47]
Kuhar DT, Henderson DK, Struble KA, Heneine W, Thomas V, Cheever LW, Gomaa A, Panlilio AL, US Public Health Service Working Group. Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis. Infection control and hospital epidemiology. 2013 Sep:34(9):875-92. doi: 10.1086/672271. Epub [PubMed PMID: 23917901]